<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000662457">
  <TermName>COPP regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat Hodgkin and non-Hodgkin lymphomas. It includes the drugs cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called COPP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000726236" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;COPP regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000726237" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen COPP&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen COPP</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento de linfomas de Hodgkin y no Hodgkin. Incluye los medicamentos ciclofosfamida, sulfato de vincristina (Oncovin), clorhidrato de procarbazina y prednisona. También se llama COPP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-04-23</DateFirstPublished>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000686548" url="/about-cancer/treatment/drugs/COPP">COPP</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
